Circulating adipokines and organ involvement in patients with systemic sclerosis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Acta Reumatológica Portuguesa

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 26219969
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis

  2014cited by this paper
• Relationship between serum leptin level and disease activity in patients with systemic sclerosis

  2014cited by this paper
• Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis

  2013cited by this paper
• 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

  2013cited by this paper
• Leptin as an immunomodulator.

  2012cited by this paper
• The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy

  2012cited by this paper
• Serum leptin, resistin and TNF‐α levels in patients with systemic sclerosis: the role of adipokines in scleroderma

  2012cited by this paper
• Immunological functions of leptin and adiponectin.

  2012cited by this paper
• Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis

  2012cited by this paper
• Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-γ.

  2011cited by this paper
• Lung involvement in systemic sclerosis.

  2011cited by this paper
• Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis.

  2011cited by this paper
• Resistin enhances the expansion of regulatory T cells through modulation of dendritic cells

  2010cited by this paper
• Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis

  2010cited by this paper
• Adiponectin and Functional Adiponectin Receptor 1 Are Expressed by Airway Epithelial Cells in Chronic Obstructive Pulmonary Disease1

  2009cited by this paper
• Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension.

  2009cited by this paper
• Adipokines: emerging therapeutic targets.

  2009cited by this paper
• Leptin and leptin receptor expression in asthma.

  2009cited by this paper
• Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers

  2008cited by this paper
• Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation

  2008cited by this paper
• Role of resistin as a marker of inflammation in systemic lupus erythematosus

  2008cited by this paper
• Adiponectin and inflammation: consensus and controversy.

  2008cited by this paper
• Interstitial lung disease in systemic sclerosis: a simple staging system.

  2008cited by this paper
• Systemic and localized scleroderma.

  2006cited by this paper
• The serum levels of resistin in rheumatoid arthritis patients.

  2006cited by this paper
• Resistin, an Adipokine with Potent Proinflammatory Properties1

  2005cited by this paper
• Transforming growth factor β1 gene (HSTGFB1) nucleotide T869C (codon 10) polymorphism is not associated with prevalence or severity of rheumatoid arthritis in a Caucasian population

  2003cited by this paper
• Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro.

  2003cited by this paper
• Resistin Promotes Endothelial Cell Activation: Further Evidence of Adipokine-Endothelial Interaction

  2003cited by this paper
• Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators.

  2003cited by this paper
• Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes.

  2003cited by this paper
• The hormone resistin links obesity to diabetes

  2001cited by this paper
• A Decreased Serum Leptin Level in Patients with Systemic Sclerosis

  2001cited by this paper
• Crystal structure of the obese protein Ieptin-E100

  1997cited by this paper
• Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

  1995cited by this paper
• Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

  1988cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper

• Serum Proteomic Markers in Patients with Systemic Sclerosis in Relation to Silica Exposure

  2025cites this paper
• Circulating adiponectin levels in systemic sclerosis: A meta-analysis and bidirectional Mendelian randomization study

  2025cites this paper
• Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review

  2023cites this paper
• The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis

  2021cites this paper
• Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis

  2021cites this paper
• The Important Role of Leptin in Modulating the Risk of Dermatological Diseases

  2021cites this paper
• Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis

  2021cites this paper
• Adiponectin Deregulation in Systemic Autoimmune Rheumatic Diseases

  2021cites this paper
• Role of adipokines in systemic sclerosis pathogenesis.

  2020influential citation
• The role of adipokines in systemic sclerosis: a missing link?

  2019cites this paper
• Adipokine expression in systemic sclerosis lung and gastrointestinal organ involvement.

  2019cites this paper
• Clinical associations of serum leptin and leptin/adiponectin ratio in systemic sclerosis

  2018influential citation
• Interfacial Adipose Tissue in Systemic Sclerosis

  2017cites this paper
• Serum adipokines levels in patients with systemic sclerosis: A meta-analysis

  2017cites this paper
• Association between Functional CYP2D6 Polymorphisms and Susceptibility to Autoimmune Diseases: A Meta-Analysis

  2017cites this paper
• Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis

  2017cites this paper
• Relationship between serum adipokine levels and radiographic progression in patients with ankylosing spondylitis

  2017cites this paper
• The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.

  2017cites this paper
• Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.

  2016cites this paper
• Do single or sequential measurements of leptin and adiponectin in plasma have prognostic value in pulmonary arterial hypertension?

  2016cites this paper